Meet With a Provider 3
These results suggest there is no excess cardiovascular risk with tirzepatide and are consistent with the improvements of numerous surrogate markers of cardiovascular health, including weight reduction, glycemic control with less hypoglycemia, blood pressure reduction, and improvements in the lipid profile
Beyond the science, this episode explores a deeper shift in how we understand addictionfrom a model centered on willpower and choice to one rooted in brain biology
Pelvic inflammatory disease in the adolescent and young adult: An update
Dorsolateral Striatum (00:37:08) States of Mind, Not Scheduling Time Predicts Habit Strength (00:38:16) Tool 3: Phase-Based Habit Plan: Phase 1 (00:46:29) Tool 3: Phase-Based Habit Plan: Phase 2 (00:55:24) Tool 3: Phase-Based Habit Plan: Phase 3 (01:01:34) Habit Flexibility (01:04:57) Should We Reward Ourselves
Whilst weight loss often improves fertility in women with obesity-related anovulation, prolonged absence of periods requires investigation
